A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites
Authors
Keywords
Vaccine adjuvants, Cancer vaccines, Melanoma/im, T lymphocytes, TLR agonists, Human
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 65, Issue 1, Pages 25-36
Publisher
Springer Nature
Online
2015-11-18
DOI
10.1007/s00262-015-1770-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- On vaccine's adjuvants and autoimmunity: Current evidence and future perspectives
- (2015) Paolo Pellegrino et al. AUTOIMMUNITY REVIEWS
- Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival
- (2015) C. M. Reed et al. CLINICAL CANCER RESEARCH
- Development of a Quantitative Real-Time RT-PCR Assay for the Detection of MAGE-A3–Positive Tumors
- (2015) Olivier Gruselle et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Nonclinical reproductive and developmental safety evaluation of the MAGE-A3 Cancer Immunotherapeutic, a therapeutic vaccine for cancer treatment
- (2015) E. Destexhe et al. REPRODUCTIVE TOXICOLOGY
- Non-clinical safety evaluation of single and repeated intramuscular administrations of MAGE-A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys
- (2014) Eric Destexhe et al. JOURNAL OF APPLIED TOXICOLOGY
- Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund’s adjuvant, with or without peptide
- (2013) Elise P. Salerno et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer
- (2012) Nadeem A. Sheikh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
- (2012) P. Sabbatini et al. CLINICAL CANCER RESEARCH
- Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine
- (2011) Craig L. Slingluff et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells
- (2011) M. K. L. MacLeod et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial
- (2009) C. L. Slingluff et al. CLINICAL CANCER RESEARCH
- MAGRIT: The Largest-Ever Phase III Lung Cancer Trial Aims to Establish a Novel Tumor-Specific Approach to Therapy
- (2009) Preeta Tyagi et al. Clinical Lung Cancer
- Evaluation of the Sentinel Immunized Node for Immune Monitoring of Cancer Vaccines
- (2008) Craig L. Slingluff et al. ANNALS OF SURGICAL ONCOLOGY
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells
- (2008) Eynav Klechevsky et al. IMMUNITY
- Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens
- (2008) Craig L. Slingluff et al. JOURNAL OF CLINICAL ONCOLOGY
- Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming
- (2008) D. Atanackovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started